Luquin Esther, Larrea Esther, Civeira Maria P, Prieto Jesús, Aldabe Rafael
Division of Hepatology and Gene Therapy (CIMA), University of Navarra, Pamplona, Spain.
Antiviral Res. 2007 Nov;76(2):194-7. doi: 10.1016/j.antiviral.2007.06.004. Epub 2007 Aug 6.
Hepatitis C virus (HCV) is remarkably efficient at establishing persistent infection. The current treatment with IFN-alpha given alone or in combination with ribavirin is ineffective in eliminating the virus in a large proportion of individuals with chronic hepatitis C. Recent data suggest that HCV blocks IFN-alpha signalling, an effect that facilitates viral persistence. We have used the HCV genomic and subgenomic replicon system to analyze the effect of structural and non-structural viral proteins on the activation of the Jak/STAT pathway and induction of antiviral activity by IFN-alpha. Our results show that IFN-alpha-mediated STAT activation (but not IFN-gamma-stimulated STAT phosphorylation) is blocked in Huh7 cell line containing the genomic replicon, while this is not observed in cells with the subgenomic replicon. In agreement with these findings, the transcriptional activity and the antiviral effect of IFN-alpha were significantly lower in cells harboring the genomic replicon than in cells with the subgenomic replicon. These results indicate that HCV structural proteins play an important role in the escape of HCV from the interferon system.
丙型肝炎病毒(HCV)在建立持续感染方面效率极高。目前单独使用α干扰素或与利巴韦林联合使用的治疗方法,在很大一部分慢性丙型肝炎患者中无法有效清除病毒。近期数据表明,HCV会阻断α干扰素信号传导,这种效应有助于病毒持续存在。我们利用HCV基因组和亚基因组复制子系统,分析病毒结构蛋白和非结构蛋白对Jak/STAT途径激活以及α干扰素诱导抗病毒活性的影响。我们的结果显示,在含有基因组复制子的Huh7细胞系中,α干扰素介导的STAT激活(而非γ干扰素刺激的STAT磷酸化)受到阻断,而在含有亚基因组复制子的细胞中未观察到这种情况。与这些发现一致,携带基因组复制子的细胞中,α干扰素的转录活性和抗病毒效果显著低于含有亚基因组复制子的细胞。这些结果表明,HCV结构蛋白在HCV逃避干扰素系统中起重要作用。